Geraldine Pannu - Jun 27, 2023 Form 4 Insider Report for Processa Pharmaceuticals, Inc. (PCSA)

Role
Director
Signature
/s/ Geraldine Pannu by Michael B. Kirwan, as Attorney-in-Fact
Stock symbol
PCSA
Transactions as of
Jun 27, 2023
Transactions value $
$0
Form type
4
Date filed
7/24/2023, 06:26 PM
Previous filing
Jan 20, 2023
Next filing
Oct 10, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction PCSA Common Stock Options Exercise +23.6K +80.18% 53.1K Jun 27, 2023 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction PCSA Restricted Stock Options Exercise $0 -23.6K -100% $0.00* 0 Jun 27, 2023 Common Stock 23.6K $0.00 Direct F1
transaction PCSA Restricted Stock Award $0 +101K $0.00 101K Jun 27, 2023 Common Stock 101K $0.00 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Vesting of time-based restricted shares.
F2 The Restricted Stock vests on the earliest of one year from date of grant or the next annual meeting of stockholders.